Swedish Orphan Biovitrum AB

At a glance

Most recent filing on November 23, 2017 — a grant by Mats Olof Wallin on Nov 21, 2017.

We hold 2 visible filings, going back to August 25, 2017.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

All 2 shown

This page is free to read, and it stops after 2 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Mats Olof Wallin CFO
2,564,533 SEKGrant
TradedNov 21, 2017FiledNov 23, 2017
Endre Rangnes Chief executive officer
5,000,000 sharesGrant
TradedAug 25, 2017FiledAug 27, 2017